Zobrazeno 1 - 5
of 5
pro vyhledávání: '"E. I. Ryabova"'
Autor:
D. S. Polyansky, E. I. Ryabova, A. A. Derkaev, N. S. Starkov, I. S. Kashapova, D. V. Shcheblyakov, A. P. Karpov, I. B. Esmagambetov
Publikováno v:
Тонкие химические технологии, Vol 19, Iss 3, Pp 240-257 (2024)
Objectives. To develop an effective technology for the cultivation of Chinese hamster ovary (CHO) cells stably producing GamP2C5 antibody which is a component I of the GamCoviMab candidate drug for emergency prevention and therapy of infection caused
Externí odkaz:
https://doaj.org/article/f7728fe6b8d24b39a617b008c5aafefc
Autor:
D. S. Polyansky, E. I. Ryabova, A. A. Derkaev, N. S. Starkov, I. S. Kashapova, D. V. Shcheblyakov, A. P. Karpov, I. B. Esmagambetov
Publikováno v:
Тонкие химические технологии, Vol 19, Iss 4, Pp 384-385 (2024)
Externí odkaz:
https://doaj.org/article/aec01be7d1d74faab305952348de0be3
Autor:
A. A. Derkaev, E. I. Ryabova, V. V. Prokofiev, I. A. Favorskaya, D. M. Grousova, I. B. Esmagambetov, I. V. Dolzhikova, D. V. Shcheblyakov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 1, Pp 76-89 (2023)
Monitoring of the proportion of immune individuals and the effectiveness of vaccination in a population involves evaluation of several important parameters, including the level of virus-neutralising antibodies. In order to combat the COVID-19 pandemi
Externí odkaz:
https://doaj.org/article/c2ef79d862e848b580cfcb9a4600ef94
Autor:
E. S. Sedova, D. N. Shcherbinin, A. S. Bandelyuk, L. V. Verkhovskaya, N. Yu. Viskova, E. D. Avdonina, V. V. Prokofiev, E. I. Ryabova, I. B. Esmagambetov, K. A. Pervoykina, E. A. Bogacheva, A. A. Lysenko, M. M. Shmarov
Publikováno v:
Тонкие химические технологии, Vol 18, Iss 1 (2023)
Objectives. To develop a technology for obtaining recombinant antibodies in a suspension culture of human HEK293 cells using transduction with recombinant adenovirus serotype 5 (rAd5) carrying genes expressing heavy and light chains of antibodies on
Externí odkaz:
https://doaj.org/article/79bb0e59cbbb4d169d7c7d7efc043e27
Autor:
E. I. Ryabova, A. A. Derkaev, I. B. Esmagambetov, D. V. Shcheblyakov, M. A. Dovgiy, D. V. Byrikhina, V. V. Prokofiev, I. P. Chemodanova
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 21, Iss 4, Pp 266-278 (2021)
Adeno-associated virus vectors are among the most promising ones for the delivery of transgenes to various organs and tissues. Recombinant adeno-associated virus (rAAV) is able to transduce both dividing and non-dividing cells, has low immunogenicity
Externí odkaz:
https://doaj.org/article/a5592cc67a714f74b4dcfdab539478b7